Heart device benefits women more
WOMEN derive twice the benefit from a device to treat heart failure as men, United States researchers said on Monday, underscoring the different ways in which men and women experience heart disease.
Women treated with a combination pacemaker and defibrillator device had a 70 percent reduction in heart failure compared with a 35 percent decline in men, they said.
"Our finding was unexpected, but extremely important because this is the only heart treatment that is clearly better in women than men," Dr Arthur Moss of the University of Rochester Medical Center, whose study appears in the Journal of the American College of Cardiology, said in a statement.
The findings come from a large Boston Scientific study of cardiac resynchronization therapy known as MADIT-CRT, in which a pacemaker is used to restore normal coordinated heart beats in people whose damaged hearts are less efficient at pumping blood.
The device also included a defibrillator used to shock dangerous heart beats back into normal rhythm.
The original study, published in 2009 in the New England Journal of Medicine, showed patients fared better with combination cardiac resynchronization therapy and a defibrillator rather than a defibrillator alone.
But it also suggested that women benefited more from resynchronization therapy than men. In the latest study, Moss and colleagues explore how much better women did, and why.
"We found... a dramatic reduction not only in heart failure events, but a very dramatic reduction in death from any cause," Moss said.
"This was far greater than expected. Men got a good result but women got a fantastic result," he said.
"We think this is the first (study) to show this."
Moss said women have often been overlooked in studies of heart disease.
Other studies have shown heart attack symptoms are much different in women than in men, something that has been publicized with the American Heart Association's "Go Red for Women" campaign.
In the MADIT-CRT trial, women were more likely to suffer heart failure caused by a viral infection of the heart, whereas in men, the condition is more often caused by blocked heart arteries, Moss said.
Women are also more likely to experience a condition known as left bundle branch block, a pattern of disorganized electrical impulses that responds well when the left side of the heart is treated with a pacemaker.
Women tend to have smaller hearts than men and Moss said the treatment works better in smaller hearts.
Women treated with a combination pacemaker and defibrillator device had a 70 percent reduction in heart failure compared with a 35 percent decline in men, they said.
"Our finding was unexpected, but extremely important because this is the only heart treatment that is clearly better in women than men," Dr Arthur Moss of the University of Rochester Medical Center, whose study appears in the Journal of the American College of Cardiology, said in a statement.
The findings come from a large Boston Scientific study of cardiac resynchronization therapy known as MADIT-CRT, in which a pacemaker is used to restore normal coordinated heart beats in people whose damaged hearts are less efficient at pumping blood.
The device also included a defibrillator used to shock dangerous heart beats back into normal rhythm.
The original study, published in 2009 in the New England Journal of Medicine, showed patients fared better with combination cardiac resynchronization therapy and a defibrillator rather than a defibrillator alone.
But it also suggested that women benefited more from resynchronization therapy than men. In the latest study, Moss and colleagues explore how much better women did, and why.
"We found... a dramatic reduction not only in heart failure events, but a very dramatic reduction in death from any cause," Moss said.
"This was far greater than expected. Men got a good result but women got a fantastic result," he said.
"We think this is the first (study) to show this."
Moss said women have often been overlooked in studies of heart disease.
Other studies have shown heart attack symptoms are much different in women than in men, something that has been publicized with the American Heart Association's "Go Red for Women" campaign.
In the MADIT-CRT trial, women were more likely to suffer heart failure caused by a viral infection of the heart, whereas in men, the condition is more often caused by blocked heart arteries, Moss said.
Women are also more likely to experience a condition known as left bundle branch block, a pattern of disorganized electrical impulses that responds well when the left side of the heart is treated with a pacemaker.
Women tend to have smaller hearts than men and Moss said the treatment works better in smaller hearts.
- About Us
- |
- Terms of Use
- |
-
RSS
- |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证:沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证:31120180004
- |
- 网络视听许可证:0909346
- |
- 广播电视节目制作许可证:沪字第354号
- |
- 增值电信业务经营许可证:沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.